ArticleScientific reports2026
Reduced cortical thickness in individuals with congenital adrenal hyperplasia (CAH).
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital adrenal hyperplasia (CAH), a genetic condition that disrupts cortisol synthesis, is associated with elevated androgen levels in females with CAH. Altered hormonal milieus have been linked to changes in brain structure, yet little is known about how CAH affects the cerebral cortex. Here, we investigated vertex-wise cortical thickness in 53 individuals with CAH (33 women and 20 men) and 53 sex- and age-matched controls (33 women and 20 men) using surface-based morphometry. There were no significant effects of biological sex and no significant diagnosis-by-sex interaction. However, there was a significant effect of diagnosis, with thinner cortices in various regions across the left and right lateral and medial surfaces in individuals with CAH compared to controls. These findings point to widespread cortical alterations in CAH, independent of sex, and extend prior evidence of structural brain variations in this endocrine disorder. The observed cortical thinning may result from multiple factors, including prenatally reduced cortisol levels, potential long-term consequences of postnatal glucocorticoid treatment, and ongoing physiological and psychosocial stressors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.